| | | | | |

Searching for New Mesothelioma Drugs Among African Plants

Doctors in Cameroon and Turkey say two types of African plants deserve more study as potential treatments for malignant mesothelioma and other intractable cancers.

The plants, including Elephantopus mollis,, Kalanchoe crenata, and four other medicinal plants, contain compounds that triggered cell death when tested on mesothelioma cells in the laboratory.

At present, there is no cure for mesothelioma and no drugs that consistently slow its progression. Even the most powerful anti-cancer drugs in use today typically have only a modest effect on this aggressive asbestos-linked malignancy.

Testing Plant Extracts on Mesothelioma Tumor Cells

For their new study, scientists at two Cameroonian universities and Anadolu University in Turkey utilized the methanol extracts from the whole Elephantopus mollis plant (EMW), the bark of the Enantia chlorantha and Lophira alata plants, and the leaves of the Kalanchoe crenata, Millettia macrophylla, and Phragmanthera capitata leaves plants.

All of these plants – which range from low ground weeds to larger evergreens, succulents, and a mistletoe – are used medicinally in Africa to treat a variety of ailments. Several have been the subjects of scientific studies.

To test their utility as anti-cancer agents for malignant mesothelioma and other cancers, researchers first performed a qualitative chemical analysis of each extract. “Phytochemical analysis revealed the presence of polyphenols, triterpenes and sterols in all extracts,” writes lead author Victor Kuete, a biochemist at the University of Dschang in Cameroon.

The extracts were then applied to directly to five different types of drug-resistant human tumor cells, including malignant mesothelioma.

New Drug Sources for Mesothelioma?

To determine what effect these extracts had on different types of tumor cells, the research team analyzed three different parameters: the life cycle stage of the treated cells, the stability of the mitochondrial membranes (known as mitochondrial membrane potential), and the levels of reactive oxygen species (ROS).

Each of these parameters give scientists crucial information about the health and viability of mesothelioma cells. Cells under stress are more likely to enter their death stages earlier, have weaker mitochondrial membranes, and produce more ROS.

What they found is that EMW induced apoptosis or cellular death by reducing mitochondrial membrane potential and increasing ROS production. The leaves of the Kalanchoe crenata plant, a tropical succulent, also induced apoptosis among the pleural mesothelioma cells by stimulating ROS production.

“The study provides evidences of the cytotoxicity of the tested plant extracts and highlights the good activity of Elephantopus mollis and Kalanchoe crenata,” concludes Dr. Kuete. “They deserve more exploration to develop novel cytotoxic drugs.”

While rare, malignant pleural mesothelioma is on the rise in many third-world countries where asbestos regulations may be lax or non-existent. Even in the US, which heavily regulates the use of asbestos, mesothelioma deaths were higher in 2015 than in 1999.

Source:

Kuete, V, et al, “Cytotoxicity of the methanol extracts of Elephantopus mollis, Kalanchoe crenata and 4 other Cameroonian medicinal plants towards human carcinoma cells”, May 25, 2017, BMC Complementary and Alternative Medicine

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…